142 related articles for article (PubMed ID: 18559616)
1. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates.
Kanter J; Khan SY; Kelher M; Gore L; Silliman CC
Clin Cancer Res; 2008 Jun; 14(12):3942-7. PubMed ID: 18559616
[TBL] [Abstract][Full Text] [Related]
2. Growth factor release from platelet concentrates: analytic quantification and characterization for clinical applications.
Durante C; Agostini F; Abbruzzese L; Toffola RT; Zanolin S; Suine C; Mazzucato M
Vox Sang; 2013 Aug; 105(2):129-36. PubMed ID: 23639058
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.
Brostjan C; Gebhardt K; Gruenberger B; Steinrueck V; Zommer H; Freudenthaler H; Roka S; Gruenberger T
Clin Cancer Res; 2008 Apr; 14(7):2065-74. PubMed ID: 18381946
[TBL] [Abstract][Full Text] [Related]
5. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
6. Platelets take up the monoclonal antibody bevacizumab.
Verheul HM; Lolkema MP; Qian DZ; Hilkes YH; Liapi E; Akkerman JW; Pili R; Voest EE
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5341-7. PubMed ID: 17855648
[TBL] [Abstract][Full Text] [Related]
7. Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood.
Zimmermann R; Loew D; Weisbach V; Strasser E; Ringwald J; Zingsem J; Eckstein R
Transfusion; 2005 Mar; 45(3):414-9. PubMed ID: 15752160
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
Charania R; Smith J; Vesely SK; Dale GL; Holter J
Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the kinetics of growth factors release from platelet gel.
Su CY; Kuo YP; Nieh HL; Tseng YH; Burnouf T
Transfusion; 2008 Nov; 48(11):2414-20. PubMed ID: 18694465
[TBL] [Abstract][Full Text] [Related]
10. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Photochem Photobiol Sci; 2007 Dec; 6(12):1275-83. PubMed ID: 18046482
[TBL] [Abstract][Full Text] [Related]
11. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates.
Wenzel F; Günther W; Baertl A; Lasshofer R; Rox J; Fischer JC; Giers G
Clin Hemorheol Microcirc; 2011; 47(4):269-78. PubMed ID: 21654056
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-I and platelet-derived growth factor levels in human milk of mothers with term and preterm neonates.
Ozgurtas T; Aydin I; Turan O; Koc E; Hirfanoglu IM; Acikel CH; Akyol M; Erbil MK
Cytokine; 2010 May; 50(2):192-4. PubMed ID: 20202860
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
14. Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences.
Dzieciatkowska M; D'Alessandro A; Burke TA; Kelher MR; Moore EE; Banerjee A; Silliman CC; West BF; Hansen KC
J Proteomics; 2015 Jan; 112():190-209. PubMed ID: 25201077
[TBL] [Abstract][Full Text] [Related]
15. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
16. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
Sloand EM; Yu M; Klein HG
Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
[TBL] [Abstract][Full Text] [Related]
17. A critical comparison of platelet preparation methods.
Vassallo RR; Murphy S
Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
[TBL] [Abstract][Full Text] [Related]
18. Standardization of a Protocol for Obtaining Platelet Rich Plasma from blood Donors; a Tool for Tissue Regeneration Procedures.
Gómez LA; Escobar M; Peñuela O
Clin Lab; 2015; 61(8):973-80. PubMed ID: 26427141
[TBL] [Abstract][Full Text] [Related]
19. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
Matsui M; Tabata Y
Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
[TBL] [Abstract][Full Text] [Related]
20. Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-beta1 in apheresis platelet concentrates during storage.
Fujihara M; Ikebuchi K; Wakamoto S; Sekiguchi S
Transfusion; 1999 May; 39(5):498-505. PubMed ID: 10336000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
